{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:53:54Z","timestamp":1790128434069,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T00:00:00Z","timestamp":1476835200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Italian Ministry of Health","award":["2008-3516"],"award-info":[{"award-number":["2008-3516"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s13402-016-0300-x","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T13:28:52Z","timestamp":1476883732000},"page":"97-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2502-4060","authenticated-orcid":false,"given":"Antonella","family":"Caivano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"La Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Simeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Girasole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Dinarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Laurenzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"De Stradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Trino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Traficante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"D\u2019Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Mansueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreste","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pietrantuono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Laurenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Del Vecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pellegrino","family":"Musto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,19]]},"reference":[{"key":"300_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc3932","volume":"15","author":"S Lin","year":"2015","unstructured":"S. Lin, R. I. Gregory, MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 15, 321\u2013333 (2015)","journal-title":"Nat Rev Cancer"},{"key":"300_CR2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"J. Hayes, P. P. Peruzzi, S. Lawler, MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 20, 460\u2013469 (2014)","journal-title":"Trends Mol Med"},{"key":"300_CR3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s13402-015-0239-3","volume":"38","author":"I Fkih","year":"2015","unstructured":"I. Fkih, M\u2019hamed, M. Privat, F. Ponelle, F. Penault-Llorca, a. Kenani, Y.J. Bignon, identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers. Cell Oncol 38, 433\u2013442 (2015)","journal-title":"Cell Oncol"},{"key":"300_CR4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s13402-016-0275-7","volume":"39","author":"V Taucher","year":"2016","unstructured":"V. Taucher, H. Mangge, J. Haybaeck, R. N. A. Non-coding, In pancreatic cancer: challenges and opportunities for clinical application. Cell Oncol 39, 295\u2013318 (2016)","journal-title":"Cell Oncol"},{"key":"300_CR5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s13402-014-0215-3","volume":"38","author":"M Shahjahani","year":"2015","unstructured":"M. Shahjahani, J. Mohammadiasl, F. Noroozi, M. Seghatoleslami, S. Shahrabi, F. Saba, N. Saki, Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis. Cell Oncol 38, 93\u2013109 (2015)","journal-title":"Cell Oncol"},{"key":"300_CR6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cpr.12262","volume":"49","author":"B Ortiz-Quintero","year":"2016","unstructured":"B. Ortiz-Quintero, Cell-free microRNAs in blood and other body fluids, as cancer biomarkers. Cell Prolif 49, 281\u2013303 (2016)","journal-title":"Cell Prolif"},{"key":"300_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s13402-014-0180-x","volume":"38","author":"M Vitiello","year":"2015","unstructured":"M. Vitiello, A. Tuccoli, L. Poliseno, Long non-coding RNAs in cancer: implications for personalized therapy. Cell Oncol 38, 17\u201328 (2015)","journal-title":"Cell Oncol"},{"key":"300_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2329-6917.1000140","volume":"2","author":"DL Zhaolei Cui","year":"2014","unstructured":"D. L. Zhaolei Cui, Circulating miRNAs: potential biomarkers for diagnosis and prognosis prediction of hematological malignancies. J Leuk 2, 1\u201315 (2014)","journal-title":"J Leuk"},{"key":"300_CR9","doi-asserted-by":"crossref","unstructured":"M. Y\u00e1\u00f1ez-M\u00f3, P.R.M. Siljander, Z. Andreu, A. Bedina Zavec, F.E. Borr\u00e0s, E.I. Buz\u00e1s, K. Buzas, E. Casal, F. Cappello, J. Carvalho, E. Col\u00e1s, A. Cordeiro-da Silva, S. Fais, J.M. Falcon-Perez, I.M. Ghobrial, B. Giebel, M. Gimona, M. Graner, I. Gursel, M. Gursel, N.H.H. Heegaard, A. Hendrix, P. Kierulf, K. Kokubun, M. Kosanovic, V. Kralj-Iglic, E. M. Kr\u00e4mer-Albers, S. Laitinen, C. L\u00e4sser, T. Lener, E. Ligeti, A. Lin\u0113, G. Lipps, A. Llorente, J. L\u00f6tvall, M. Man\u010dek-Keber, A. Marcilla, M. Mittelbrunn, I. Nazarenko, E.N.M. Nolte-Hoen\u2018t, T.A. Nyman, L. O\u2019Driscoll, M. Olivan, C. Oliveira, \u00c9. P\u00e1llinger, H.A. del Portillo, J. Revent\u00f3s, M. Rigau, E. Rohde, M. Sammar, F. S\u00e1nchez-Madrid, N. Santar\u00e9m, K. Schallmoser, M. Stampe Ostenfeld, W. Stoorvogel, R. Stukelj, S.G. Van der Grein, M.H. Vasconcelos, M.H.M. Wauben, O. De Wever, Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 4, 319\u2013325 (2015)","DOI":"10.3402\/jev.v4.27066"},{"key":"300_CR10","doi-asserted-by":"crossref","unstructured":"S. Raimondo, C. Corrado, L. Raimondi, G. De Leo, R. Alessandro, Role of extracellular vesicles in hematological malignancies. Biomed Res Int 2015, 1\u20139 (2015)","DOI":"10.1155\/2015\/821613"},{"key":"300_CR11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.devcel.2016.04.019","volume":"37","author":"LM Desrochers","year":"2016","unstructured":"L. M. Desrochers, M. A. Antonyak, R. A. Cerione, Extracellular vesicles: satellites of information transfer in cancer and stem cell biology. Dev Cell 37, 301\u2013309 (2016)","journal-title":"Dev Cell"},{"key":"300_CR12","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.18632\/oncotarget.6791","volume":"7","author":"L De Luca","year":"2015","unstructured":"L. De Luca, S. Trino, I. Laurenzana, V. Simeon, G. Calice, S. Raimondo, M. Podest\u00e0, M. Santodirocco, L. Di Mauro, F. La Rocca, A. Caivano, A. Morano, F. Frassoni, D. Cilloni, L. Del Vecchio, P. Musto, MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation. Oncotarget 7, 6676\u20136692 (2015)","journal-title":"Oncotarget"},{"key":"300_CR13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.17980\/2015.208","volume":"1","author":"I Tatischeff","year":"2015","unstructured":"I. Tatischeff, Cell-derived extracellular vesicles open new perspectives for cancer research. Cancer Res Front 1, 208\u2013224 (2015)","journal-title":"Cancer Res Front"},{"key":"300_CR14","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1007\/s13277-015-3741-3","volume":"36","author":"A Caivano","year":"2015","unstructured":"A. Caivano, I. Laurenzana, L. De Luca, F. La Rocca, V. Simeon, S. Trino, F. D\u2019Auria, A. Traficante, M. Maietti, T. Izzo, G. D\u2019Arena, G. Mansueto, G. Pietrantuono, L. Laurenti, P. Musto, L. Del Vecchio, High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumour Biol 36, 9739\u20133752 (2015)","journal-title":"Tumour Biol"},{"key":"300_CR15","first-page":"497","volume":"1792","author":"I Faraoni","year":"2009","unstructured":"I. Faraoni, F. R. Antonetti, J. Cardone, E. Bonmassar, miR-155 gene: a typical multifunctional microRNA. Biochem. Biophys. Acta 1792, 497\u2013505 (2009)","journal-title":"Biochem. Biophys. Acta"},{"key":"300_CR16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/imm.12468","volume":"145","author":"R Mashima","year":"2015","unstructured":"R. Mashima, Physiological roles of miR-155. Immunology 145, 323\u2013333 (2015)","journal-title":"Immunology"},{"key":"300_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.12.009","volume":"532","author":"TS Elton","year":"2013","unstructured":"T. S. Elton, H. Selemon, S. M. Elton, N. L. Parinandi, Regulation of the MIR155 host gene in physiological and pathological processes. Gene 532, 1\u201312 (2013)","journal-title":"Gene"},{"key":"300_CR18","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1073\/pnas.0610983104","volume":"104","author":"RW Georgantas","year":"2007","unstructured":"R. W. Georgantas, R. Hildreth, S. Morisot, J. Alder, C. G. Liu, S. Heimfeld, G. A. Calin, C. M. Croce, C. I. Civin, CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A 104, 2750\u20132755 (2007)","journal-title":"Proc Natl Acad Sci U S A"},{"key":"300_CR19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-016-0518-2","volume":"15","author":"C-H Yeh","year":"2016","unstructured":"C.-H. Yeh, R. Moles, C. Nicot, Clinical significance of microRNAs in chronic and acute human leukemia. Mol Cancer 15, 37\u201353 (2016)","journal-title":"Mol Cancer"},{"key":"300_CR20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jmr.2170","volume":"25","author":"M Girasole","year":"2012","unstructured":"M. Girasole, S. Dinarelli, G. Boumis, Structural, morphological and nanomechanical characterisation of intermediate states in the ageing of erythrocytes. J Mol Recognit 25, 285\u2013291 (2012)","journal-title":"J Mol Recognit"},{"key":"300_CR21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"M. Colombo, G. Raposo, C. Th\u00e9ry, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30, 255\u2013289 (2014)","journal-title":"Annu Rev Cell Dev Biol"},{"key":"300_CR22","first-page":"267","volume":"4","author":"D Zocco","year":"2014","unstructured":"D. Zocco, P. Ferruzzi, F. Cappello, W. P. Kuo, Extracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugs. Front. Oncologia 4, 267\u2013274 (2014)","journal-title":"Oncologia"},{"key":"300_CR23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/j.seminhematol.2016.05.005","volume":"53","author":"A Gallamini","year":"2016","unstructured":"A. Gallamini, M. Hutchings, S. Ramadan, Clinical presentation and staging of Hodgkin lymphoma. Semin Hematol 53, 148\u2013154 (2016)","journal-title":"Semin Hematol"},{"key":"300_CR24","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1182\/blood-2014-12-618470","volume":"125","author":"Y-Y Yeh","year":"2015","unstructured":"Y.-Y. Yeh, H. G. Ozer, A. M. Lehman, K. Maddocks, L. Yu, A. J. Johnson, J. C. Byrd, Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling. Blood 125, 3297\u20133305 (2015)","journal-title":"Blood"},{"key":"300_CR25","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2013-01-478222","volume":"122","author":"A Ferrajoli","year":"2013","unstructured":"A. Ferrajoli, T. D. Shanafelt, C. Ivan, M. Shimizu, K. G. Rabe, N. Nouraee, M. Ikuo, A. K. Ghosh, S. Lerner, L. Z. Rassenti, L. Xiao, J. Hu, J. M. Reuben, S. Calin, M. J. You, J. T. Manning, W. G. Wierda, Z. Estrov, S. O\u2019Brien, T. J. Kipps, M. J. Keating, N. E. Kay, G. A. Calin, Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood 122, 1891\u20131899 (2013)","journal-title":"Blood"},{"key":"300_CR26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.seminoncol.2016.02.009","volume":"43","author":"SA Parikh","year":"2016","unstructured":"S. A. Parikh, T. D. Shanafelt, Prognostic factors and risk stratification in chronic lymphocytic leukemia. Semin Oncol 43, 233\u2013240 (2016)","journal-title":"Semin Oncol"},{"key":"300_CR27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.clml.2013.02.007","volume":"13","author":"A Sacco","year":"2013","unstructured":"A. Sacco, Y. Zhang, P. Maiso, S. Manier, G. Rossi, S. P. Treon, I. M. Ghobrial, A. M. Roccaro, Aberrations in Waldenstr\u00f6m macroglobulinemia. Clin Lymphoma Myeloma Leuk 13, 205\u2013210 (2013)","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"300_CR28","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1182\/blood-2008-09-178228","volume":"113","author":"AM Roccaro","year":"2009","unstructured":"A. M. Roccaro, A. Sacco, C. Chen, J. Runnels, X. Leleu, F. Azab, A. K. Azab, X. Jia, H. T. Ngo, M. R. Melhem, N. Burwick, L. Varticovski, C. D. Novina, B. J. Rollins, K. C. Anderson, I. M. Ghobrial, microRNA aberrations in Waldenstr\u00f6m macroglobulinemia. Blood 113, 4391\u20134402 (2009)","journal-title":"Blood"},{"key":"300_CR29","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2008-08-174961","volume":"113","author":"P Morel","year":"2009","unstructured":"P. Morel, A. Duhamel, P. Gobbi, M. A. Dimopoulos, M. V. Dhodapkar, J. McCoy, J. Crowley, E. M. Ocio, R. G. Sanz, S. P. Treon, V. Leblond, R. A. Kyle, B. Barlogie, G. Merlini, International prognostic scoring system for Waldenstr\u00f6m macroglobulinemia. Blood 113, 4163\u20134170 (2009)","journal-title":"Blood"},{"key":"300_CR30","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.1038\/srep11295","volume":"5","author":"NI Hornick","year":"2015","unstructured":"N. I. Hornick, J. Huan, B. Doron, N. A. Goloviznina, J. Lapidus, B. H. Chang, P. Kurre, Serum exosome microRNA as a minimally-invasive early biomarker of AML. Sci Report 5, 11295\u201311307 (2015)","journal-title":"Sci Report"},{"key":"300_CR31","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3324\/haematol.2011.040592","volume":"96","author":"HJM Jonge de","year":"2011","unstructured":"H. J. M. de Jonge, P. J. M. Valk, E. S. J. M. de Bont, J. J. Schuringa, G. Ossenkoppele, E. Vellenga, G. Huls, Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD. Haematologica 96, 1310\u20131317 (2011)","journal-title":"Haematologica"},{"key":"300_CR32","doi-asserted-by":"crossref","unstructured":"I. De Kouchkovsky, M. Abdul-Hay, Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J 6, e441 (2016)","DOI":"10.1038\/bcj.2016.50"},{"key":"300_CR33","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1038\/onc.2011.579","volume":"31","author":"DW Lee","year":"2012","unstructured":"D. W. Lee, M. Futami, M. Carroll, Y. Feng, Z. Wang, M. Fernandez, Z. Whichard, Y. Chen, S. Kornblau, E. J. Shpall, C. E. Bueso-Ramos, S. J. Corey, Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155. Oncogene 31, 4085\u20134094 (2012)","journal-title":"Oncogene"},{"key":"300_CR34","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3109\/10428190903147645","volume":"50","author":"A Pons","year":"2009","unstructured":"A. Pons, B. Nomdedeu, A. Navarro, A. Gaya, B. Gel, T. Diaz, S. Valera, M. Rozman, M. Belkaid, E. Montserrat, M. Monzo, Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma 50, 1854\u20131859 (2009)","journal-title":"Leuk Lymphoma"},{"key":"300_CR35","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"P. L. Greenberg, N. S. Young, N. Gattermann, Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120, 2454\u20132465 (2012)","journal-title":"Blood"},{"key":"300_CR36","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"D. A. Arber, A. Orazi, R. Hasserjian, J. Thiele, M. J. Borowitz, M. M. Le Beau, C. D. Bloomfield, M. Cazzola, J. W. Vardiman, Reclassifying myelodysplastic syndromes: what\u2019s where in the new WHO and why. Blood 127, 2391\u20132405 (2016)","journal-title":"Blood"},{"key":"300_CR37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ajh.24253","volume":"91","author":"N Gangat","year":"2015","unstructured":"N. Gangat, M. M. Patnaik, A. Tefferi, Myelodysplastic syndromes: contemporary review and how we treat. Am J Hematol 91, 76\u201389 (2015)","journal-title":"Am J Hematol"},{"key":"300_CR38","doi-asserted-by":"crossref","unstructured":"P. Krzeminski, M.E. Sarasquete, I. Misiewicz-Krzeminska, R. Corral, L.A. Corchete, A.A. Mart\u00edn, R. Garcia-Sanz, J.F. San-Miguel, N. C. Gutierrez, Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma. Biochim Biophys Acta 1849, 353\u2013366 (2015)","DOI":"10.1016\/j.bbagrm.2014.12.002"},{"key":"300_CR39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/1061186X.2014.951653","volume":"23","author":"M Feng","year":"2014","unstructured":"M. Feng, X. Luo, C. Gu, J. Fei, Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells. J Drug Target 23, 59\u201366 (2014)","journal-title":"J Drug Target"},{"key":"300_CR40","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2009-08-237495","volume":"114","author":"M Lionetti","year":"2009","unstructured":"M. Lionetti, M. Biasiolo, L. Agnelli, K. Todoerti, L. Mosca, S. Fabris, G. Sales, G. L. Deliliers, S. Bicciato, L. Lombardi, S. Bortoluzzi, A. Neri, Identification of microRNA expression patterns and definition of a microRNA\/mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood 114, e20 (2009)","journal-title":"Blood"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-016-0300-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13402-016-0300-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-016-0300-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T19:45:16Z","timestamp":1601149516000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-016-0300-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,19]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1007\/s13402-016-0300-x","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,19]]}}}